Business
Novo Nordisk CEO to Step Down Amid Obesity Drug Market Struggles
Novo Nordisk announced Friday that CEO Lars Fruergaard Jorgensen will step down. This follows a sharp drop in the
May 16, 2025
No Comments
Novo Nordisk announced Friday that CEO Lars Fruergaard Jorgensen will step down. This follows a sharp drop in the
Johnson & Johnson plans to increase U.S. investments by 25% to over $55 billion in the next four years.
AstraZeneca will acquire biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec’s “Engineered NanoBody Lentiviral (ENaBL) platform can genetically
